Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global “public health vigilance,” according to a study by an international team led by…
A team of researchers led by the University of Arizona Steele Children’s Research Center discovered that curcumin—the bioactive molecule derived from the spice turmeric—blocks the protein cortactin in colon cancer.…
The Arizona Commerce Authority (ACA) has selected 18 recipients for AZ Fast Grant, a highly competitive grant program that provides qualified Arizona-based, early stage technology companies with intensive training and…
The Translational Genomics Research Institute (TGen) and Ceres Nanosciences, Inc. (Ceres) today announced a development collaboration to benefit patients with cancer, infectious diseases, and other life-threatening illnesses. TGen, at the…
The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of…
Biogeochemist Ariel Anbar has been selected as Arizona State University’s first Howard Hughes Medical Institute (HHMI) Professor. This distinguished honor recognizes Anbar’s pioneering research and teaching. He is one of…
As part of the State’s FY 2015 budget, the Maricopa Community Colleges received $1.4 million to bolster educational efforts in Science, Technology, Engineering and Math (STEM) and Workforce areas. This…
Merz and Ulthera, Inc. today announced that they have entered a definitive merger agreement, pursuant to which Merz will acquire global medical device company Ulthera, a deal which will accelerate…
AZBio Expo 2014 had “aha moments” at every turn. With over 250 entrepreneurs, innovators, business leaders, legislators, scientists and researchers in attendance, the energy was sizzling and the outlook endless.…
Northern Arizona University (NAU) and the Translational Genomics Research Institute (TGen) announced a five-year agreement to promote innovation and quality research benefiting Arizona. The NAU-TGen Memorandum of Understanding (MOU) implements…
RCT Ventures, an early-stage biomedical investment program of Tucson-based Research Corporation Technologies Inc., announced that Fibralign Corporation is the winner of the 2014 MedTech Innovator competition held during the 22nd…
Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center announced Arizona Diamondbacks President and CEO Derrick Hall will be joining its Board of Directors. “As a prostate cancer…
